US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust Dorsey Wright Dynamic Focus 5 ETF

42.28

0.0000

Volume:4

Turnover:170.02

Market Cap:109.92M

PE:- -

High:42.28

Open:42.28

Low:42.28

Close:42.28

52wk High:44.23

52wk Low:33.81

Shares:2.60M

Float Shares:2.60M

Volume Ratio:0.00

T/O Rate:0.00%

Dividend:0.55

Dividend Rate:1.30%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Treasury's Buyback Push Could Weaken Dollar, Deutsche Bank Warns

Press Release: Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Press Release: aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

Rein Therapeutics Announces Publication of Landmark LTI-03 Clinical Data in Nature Communications

Joint Currency Market Action by South Korea and Japan Pushes Won to Nine-Month Peak

Federal Reserve's Abandonment of Forward Guidance Sparks Policy Divergence Bets, Dollar Under Short-Term Pressure

Japanese Yen Hits Four-Decade Low Against US Dollar, Breaching 163 for First Time Since 1986

Expert Opinion: Policy Pressures Currency, Yen May Set New Low Against Dollar

aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026

Bitcoin slips below the cloud as Ethereum and Altcoins show relative strength

South Korean Won Strengthens Against US Dollar, Reaching Highest Level Since Late May

Quantitative Hedge Funds Face Sharpest Drawdown Since 2023 as Momentum Strategy Falters

Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

Why Is United Therapeutics Stock Soaring Monday?

BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/FVC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FVC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FVC\",,,,,undefined,":{"symbol":"FVC","market":"US","secType":"STK","nameCN":"First Trust Dorsey Wright Dynamic Focus 5 ETF","latestPrice":42.275,"timestamp":1787667062560,"preClose":42.275,"halted":0,"volume":4,"delay":0,"changeRate":0,"floatShares":2600002,"shares":2600002,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"08-25 10:50:31 EDT","open":42.275,"high":42.275,"low":42.275,"amount":170.024,"amplitude":0,"askPrice":42.63,"askSize":5000,"bidPrice":42.42,"bidSize":5000,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":42.275,"sharesOutstanding":2750002,"nav":42.69,"aum":110994085.38,"dividendRate":0.013001,"bidAskSpread":0.004204,"postHourTrading":{"tag":"盘后","latestPrice":42.23,"preClose":42.275,"latestTime":"16:10 EDT","volume":7,"amount":295.675,"timestamp":1787602205240,"change":-0.045,"changeRate":-0.001064,"amplitude":0},"volumeRatio":0.00226},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FVC\",,,,,undefined,":{"symbol":"FVC","floatShares":2600002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.00226,"shares":2600002,"dividePrice":0.5496,"high":42.275,"amplitude":0,"preClose":42.275,"low":42.275,"week52Low":33.8116,"pbRate":"--","week52High":44.2299,"institutionHeld":0,"latestPrice":42.275,"eps":0,"divideRate":0.013001,"volume":4,"delay":0,"ttmEps":0,"open":42.275,"prevYearClose":36.368,"prevWeekClose":42.7,"prevMonthClose":40.1018,"prevQuarterClose":43.7984,"fiveDayClose":42.11,"twentyDayClose":40.1972,"sixtyDayClose":41.6341},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FVC\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"FVC","amount":0.0006,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2025-12-12","symbol":"FVC","amount":0.3232,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FVC","amount":0.2262,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-26","symbol":"FVC","amount":0.2677,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-06-30"},{"date":"2025-03-27","symbol":"FVC","amount":0.1174,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-27","defaultRemindTime":1743082200000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-31","payableDate":"2025-03-27","currency":"USD","dateTimestamp":1743048000000,"payDate":"2025-03-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FVC\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-21","recordDate":"2016-09-23","paymentDate":"2016-09-30","value":0.0365,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0068,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.1017,"currency":"USD"},{"executeDate":"2017-06-22","recordDate":"2017-06-26","paymentDate":"2017-06-30","value":0.0169,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":"2017-09-22","paymentDate":"2017-09-29","value":0.0459,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FVC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FVC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1193847087","title":"Treasury's Buyback Push Could Weaken Dollar, Deutsche Bank Warns","url":"https://stock-news.laohu8.com/highlight/detail?id=1193847087","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193847087?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:10","pubTimestamp":1787555450,"startTime":"0","endTime":"0","summary":"With U.S. debt surpassing the $40 trillion mark, global markets have shifted their focus from the sheer scale of the figure to how policymakers intend to manage the immense pressure it creates. The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVDV","AVRY","BGRO","BCPL","FLXI","SFTX","ACWX","FFDI","RFDI","HCRB","BRIE","JDVI","ROMO","FTRB","DIVA","SPCT","PIZ","USAF","MULT","LEXI","RAYD","BK4582","RFCI","BK4585","CGV","WLDR","BGH","WWJD","BK4550","PTIN","VGFPF","RODE","AHLT","TOUS","TINS","YLDE","GLBL","FIXP","JFLX","SSXU","CVY","SIO","BINT","IYLD","UIVM","XCOR","DWFI","QTAC","TSPX","ANEW","JHMD","CRXP","AAVM","UNIY","QBIV","ESGX","PZIV","JIII","TABD","PPIE","MVFG","RDFI","SCHC","FIRS","CDIG","RTRE","SMOM","JCPI","SLVX","TUG","WLTG","MNVT","FITZ","FTHB","CFIT","AVNV","VSLU","HIDV","BK4588","APIE","QWLD","INTF","INTL","FARX","JPIB","TBG","WTMF","RJMG","FAX","VEN","DWCR","PDN","NTZG","PIM","PYLD","IVAL","DFCF","FRWD","OGIG","LVIG","FDCE","EAGL","AMAX","FFUT","TOAO","PSDM","DXIV","FPAG","GAL","JFLI","FHIL","FPAA","RLY","TOTL","IQDY","EDGI","IDMO","GDMA","FID","GQGU","AQEC","EPIN","CGGE","XAGG","GIEQ","BINV","RGLO","BKIV","BKFI","PRAE","TAEQ","RINT","DYFI","IFV","PEXL","SNTH","TEK","CGDV","DTAN","DDX","ERNZ","PLGI","TCTL","WBND","NBGX","CGIC","WSGE","ESIM","TISC","ROIS","IMTM","TPUT","RDMX","ITDE","DDWM","IDEQ","EDGF","AVIV","MFSG","TMSF","FVC","ATFV","FLSP","RIGS","VYMI","TOAK","DFAX","NELS","IVLU","DBAW","DMX","FLDZ","URTH","MXI","GMOD","ISDX","ASGM","JPIE","ISEP","RW","TOK","TILC","CGUS","QDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972189","title":"Press Release: Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972189","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972189?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:00","pubTimestamp":1786536000,"startTime":"0","endTime":"0","summary":"double-blind, placebo-controlled global trial evaluating two doses of. AP01 dosed twice daily in patients with progressive pulmonary fibrosis. . This 52-week trial is designed to assess safety and efficacy of. AP01, with a primary endpoint of change in lung function measured by. forced vital capacity . The study overenrolled beyond its target. enrollment of 375, with a total of 398 patients randomized into three. treatment cohorts. Topline data are anticipated in the second half of. -- In September 2026, the Company plans to present two abstracts at the ERS. Congress in Barcelona, Spain. The first poster will highlight data. modeling effective AP01 distribution throughout the target tissue in both. healthy and idiopathic pulmonary fibrosis  lungs. The second poster. will describe the integration of patient perspectives into clinical trial. design. Detailed poster session information will be provided in advance","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","AVLN","IDNA","MEDX","BK4007","NVIB","HYLG","FVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658089139","title":"Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2658089139","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658089139?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:00","pubTimestamp":1786536000,"startTime":"0","endTime":"0","summary":"Completed enrollment of MIST global Phase 2b trial of AP01 with 398 patients; topline data expected in the second half of 2027 Two abstracts accepted for presentation at the European Respiratory Socie","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343572/0/en/avalyn-reports-second-quarter-2026-financial-results-and-recent-business-highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","HYLG","NVIB","IDNA","FVC","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657625012","title":"Press Release: aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD","url":"https://stock-news.laohu8.com/highlight/detail?id=2657625012","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657625012?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:01","pubTimestamp":1786132860,"startTime":"0","endTime":"0","summary":"resources to support the efzofitimod program in ILD in anticipation of. comments from the FDA on a protocol submitted for a planned Phase 3 study. in pulmonary sarcoidosis and to complete the Phase 2 EFZO-CONNECT. -- Jill Broadfoot, aTyr's Chief Financial Officer , will step down as. of September 30, 2026, and transition to serve as a consultant t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4555","BK4588","FVC","TM","03160","BK4604","BK4139","ATYR","BK4099","CFO","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657557626","title":"aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD","url":"https://stock-news.laohu8.com/highlight/detail?id=2657557626","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657557626?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:01","pubTimestamp":1786132860,"startTime":"0","endTime":"0","summary":"Company awaiting comments from FDA by the end of August 2026 on protocol submitted for planned Phase 3 study of efzofitimod in patients with pulmonary sarcoidosis. Workforce reduction of approximately","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/07/3341378/0/en/atyr-pharma-announces-second-quarter-2026-results-program-prioritization-and-corporate-restructuring-to-support-efzofitimod-program-in-ild.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","CFO","FVC","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656556464","title":"Rein Therapeutics Announces Publication of Landmark LTI-03 Clinical Data in Nature Communications","url":"https://stock-news.laohu8.com/highlight/detail?id=2656556464","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656556464?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:00","pubTimestamp":1785844800,"startTime":"0","endTime":"0","summary":"Data support ongoing Phase 2 “RENEW” trialFirst-in-human clinical study produced measurable reductions in multiple markers of lung scarring and inflammation in IPF patientsStudy confirms LTI-03 was sa","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/04/3338229/28652/en/Rein-Therapeutics-Announces-Publication-of-Landmark-LTI-03-Clinical-Data-in-Nature-Communications.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSL","BK4211","LARK","TSDD","TSLW","TSYY","LENZ","TSLL","TSLI","TSII","TSLO","RNTX","TSLQ","TSLG","07766","BK4007","09766","BK4539","TSLY","TSLP","FVC","CRSH","09366","07366","TEST","TLA","TSLT","BK4139","TSLZ","TSLR","TESL","TSLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114451296","title":"Joint Currency Market Action by South Korea and Japan Pushes Won to Nine-Month Peak","url":"https://stock-news.laohu8.com/highlight/detail?id=1114451296","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114451296?lang=en_us&edition=fundamental","pubTime":"2026-07-31 09:20","pubTimestamp":1785460856,"startTime":"0","endTime":"0","summary":"The South Korean won strengthened to a nine-month high against the US dollar during Friday morning trading, following what analysts suspect was intervention by local foreign exchange authorities to...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UIVM","ISEP","AVNV","NBGX","APIE","RDMX","JIII","JPIB","WLTG","DFCF","WWJD","FIRS","PEXL","BKIV","FPAG","EDGI","GMOD","DXIV","SLVX","VSLU","ISDX","FLXI","ACWX","ESIM","IDEQ","IYLD","TISC","ASGM","ITDE","TINS","BGH","JCPI","NELS","JDVI","GLBL","RTRE","DDX","PPIE","FITZ","JPIE","TUG","GAL","XAGG","BKFI","GDMA","SMOM","CGV","IVAL","RFCI","TBG","KUmain","CRXP","FPAA","DIVA","JFLX","QDF","URTH","BK4585","DWFI","FDCE","GIEQ","FTRB","QTAC","ATFV","NTZG","FLKR","WSGE","PYLD","TOTL","WTMF","SSXU","DBAW","PSDM","GQGU","USAF","PTIN","EWY","SCHC","YLDE","SPCT","RIGS","TILC","AHLT","DYFI","BGRO","FIXP","FLSP","IVLU","WBND","ROIS","RINT","ANEW","DFAX","PDN","TABD","AAVM","BRIE","VEN","RLY","CDIG","CVY","OGIG","TMSF","PZIV","FVC","ERNZ","XCOR","IMTM","FID","TOUS","CGDV","RFDI","PIM","LEXI","HCRB","AMAX","TAEQ","BCPL","RODE","TOAK","EDGF","FRWD","BK4550","TOAO","TCTL","IQDY","MVFG","BINV","FHIL","AVDV","DTAN","MULT","CGUS","RJMG","SFTX","VGFPF","IDMO","BK4582","WLDR","SIO","AVRY","MNVT","FFDI","FTHB","PLGI","RAYD","IFV","TPUT","JFLI","CGGE","DWCR","QWLD","ROMO","RW","INTL","VYMI","JHMD","TOK","CGIC","INTF","UNIY","BINT","EPIN","BK4535","FFUT","MKOR","KORU","FAX","SNTH","QBIV","MFSG","PIZ","ESGX","FARX","AQEC","BK4588","CFIT","AVIV","MXI","EAGL","DDWM","DMX","HIDV","RGLO","TEK","LVIG","TSPX","PRAE","FLDZ","RDFI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197219335","title":"Federal Reserve's Abandonment of Forward Guidance Sparks Policy Divergence Bets, Dollar Under Short-Term Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1197219335","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197219335?lang=en_us&edition=fundamental","pubTime":"2026-07-30 14:56","pubTimestamp":1785394565,"startTime":"0","endTime":"0","summary":"The Federal Reserve's monetary policy meeting on July 29 concluded with Chair Kevin Warsh announcing a hold on interest rates and the abandonment of forward guidance, a move that has fueled market...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMPB","HIBL","FLDZ","EDGF","PDN","CIVG","RFDI","LVIG","EDV","VEN","VFH","FEM","SPYI","AGG","VCIT","DBAW","ZFmain","MVFG","WLTG","FITZ","JDVI","JPST","WTMF","FDCE","XBIL","AVDV","SDS","APIE","ASGM","SPYU","SLVX","SPY","JPIB","FPAA","FTRB","SPYQ","ROIS","INTL","ISHG","UBmain","VGFPF","PBDC","BK4585","VYMI","IFV","AHLT","UNIY","URTH","TUG","USHY","KRX","MFSG","SPXS","XLF","TFJL","MINT","SFTX","RDFI","BGH","TIP","BK4504","TBJL","TSYW","WLDR","AVNV","SSO","SNTH","CDIG","JIII","VGLT","SPYB","UIVM","BINV","GBIL","FLSP","BK4561","HCRB","BBIB","CGV","MUB","TAEQ","GOLY","TISC","BK4582","AMAX","NELS","BK4588","TOUS","XAGG","YSPY","SPXL","SKRE","TCTL","DFAX","FTHB","UUP","CGDV","BOND","US2Y.BOND","ISDX","ATFV","JFLI","CFIT","MULT","SPCT","RLY","SPUU","INTF","HK0000934320.USD","OEF","GMOD","USAF","FRWD","PEXL","DPST","BKFI","BBLB","OGIG","SHY","DBND","TINS","WAMA","US10Y.BOND","EBUF","MNVT","AVIV","US7Y.BOND","RINT","VOO","TLT","PSDM","IEI","RGLO","IVAL","SH","SPDN","BIL","JPIE","UPRO","GLBL","WWJD","SHV","TBT","ANEW","TEK","SCHC","NTZG","BSV","EPIN","AVRY","BBSB","PRAE","PLGI","BWZ","BK4550","DMAX","UBT","RAUS","VSLU","PIZ","FIRS","TBG","BCPL","SPXU","JULD","SIO","DYFI","IMTM","FARX","MESmain","ZTmain","BKIV","EAGL","FAX","HMOP","TSPX","TMSF","ERNZ","KRE","BK4534","JFLX","SPYH","MXI","US12M.BOND","IDEQ","US5Y.BOND","FAZ","GAL","JCPI","RODE","HYG","LQD","ACWX","FLGV","TLH","BWX","AAVM","FIXP","IGOV","DWCR","SPYM","BGRO","DMX","CVY","VCSH","VEXC","TLTX","CRXP","XLRI","ITDE","QDF","MUNX","NBGX","BK4535","YLDE","KBWB","IVLU","PPIE","BOXX","RDMX","GIEQ","TYO","AQEC","WBND","BK4559","PYLD","PIM","CGGE","GQGU","LIAJ","TLTW","QBIV","FHIL","DDX","TOAK","DTAN","TOTL","RAYD","ESGX","TMF","VGIT","FFDI","CGIC","DDWM","DFCF","MMAX","NEMD","CGUS","ISEP","TOK","TLTI","RW","TNmain","XCOR","SGOV","GDMA","IAT","IQDY","DIVA","RTRE","BK4581","FFUT","TABD","SSXU","IDMO","FID","RJMG","NGHT","PZIV","IVV","IEF","JHMD","DXIV","ROMO","UDN","VGSH","RFCI",".SPX","OOQB","BINT","SMAX","US30Y.BOND","FPAG","SMOM","ESmain","SCHO","DWFI","ZROZ","US3Y.BOND","PTIN","TBIL","TOAO","ZBmain","BRIE","TILC","OEX","QWLD","MYCN","KBE","US6M.BOND","IYLD","WSGE","GOVT","HIDV","RIGS","QTAC","ESIM","LEXI","BND","FVC","EDGI","FLXI","TPUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177808976","title":"Japanese Yen Hits Four-Decade Low Against US Dollar, Breaching 163 for First Time Since 1986","url":"https://stock-news.laohu8.com/highlight/detail?id=1177808976","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177808976?lang=en_us&edition=fundamental","pubTime":"2026-07-22 09:14","pubTimestamp":1784682882,"startTime":"0","endTime":"0","summary":"The Japanese yen has plunged to its weakest level against the US dollar in nearly 40 years, breaking through the 163 threshold for the first time since 1986.In New York foreign exchange markets on...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMAX","AVNV","BK4585","PEXL","SSXU","CVY","DDX","GLBL","WWJD","WBND","IDEQ","BINT","EAGL","RJMG","FHIL","RW","UNIY","IFV","INTL","APIE","PLGI","YCL","MNVT","IMTM","IYLD","CDIG","YLDE","CFIT","QBIV","BKFI","RFDI","TOAO","JPYmain","MJYmain","HEWJ","JIII","FFUT","RGLO","ISRVF","DTAN","VYMI","WTMF","CGV","GQGU","JPIB","OGIG","PRAE","PYLD","EDGF","PIM","TSPX","TOAK","ROIS","DWFI","PPIE","LVIG","MVFG","RLY","TOUS","GMOD","FPAA","FXY","XCOR","YCS","BK4550","RDFI","RFCI","NBIE","JHMD","TPUT","TABD","FAX","IVAL","DYFI","FFDI","BGH","AAVM","IVLU","DIVA","CGIC","RTRE","TCTL","MFSG","FTRB","JPIE","TMSF","LEXI","FLSP","NELS","VEN","QWLD","SNTH","CGUS","DWCR","RAYD","RINT","MULT","TOTL","AQEC","VGFPF","DBAW","RIGS","HCRB","HIDV","ATFV","JCPI","PIZ","GDMA","AVIV","PSDM","TAEQ","BCPL","EWJ","ERNZ","ASGM","SCHC","FDCE","RODE","INTF","NBGX","DDWM","PZIV","CGDV","URTH","FVC","SLVX","USDJPY.FOREX","TBG","TISC","UIVM","CGGE","ESGX","WLDR","TEK","RDMX","TUG","BGRO","BRIE","FTHB","GAL","FLDZ","EPIN","CRXP","DFCF","FIRS","DXIV","ISEP","FID","BINV","ACWX","GIEQ","BK4582","EDGI","FPAG","FITZ","SIO","ANEW","ISDX","ITDE","TOK","FRWD","QTAC","DMX","SMOM","FIXP","TINS","FLXI","DFAX","WSGE","AHLT","TILC","MXI","NTZG","USAF","QDF","VSLU","IQDY","PDN","IDMO","PTIN","WLTG","XAGG","FARX","AVRY","ROMO","SPCT","JDVI","JFLI","JFLX","BKIV","SFTX","BK4588","ESIM","AVDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130496022","title":"Expert Opinion: Policy Pressures Currency, Yen May Set New Low Against Dollar","url":"https://stock-news.laohu8.com/highlight/detail?id=1130496022","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130496022?lang=en_us&edition=fundamental","pubTime":"2026-07-18 07:10","pubTimestamp":1784329835,"startTime":"0","endTime":"0","summary":"An expert from RSM Consulting, Joe Brusuelas, indicated on the 17th that the Japanese yen is highly likely to continue weakening, potentially breaching the 170 yen per US dollar level, before the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBG","TOUS","DDX","BGH","AHLT","JPIE","ISEP","BK4588","FID","WTMF","WWJD","JCPI","GDMA","ISRVF","NTZG","AVDV","EAGL","HCRB","INTF","QDF","WBND","YCS","IYLD","UNIY","FTRB","IVAL","GLBL","RLY","USDJPY.FOREX","LEXI","AAVM","CGGE","SCHC","SIO","ITDE","JHMD","URTH","PRAE","DXIV","RTRE","RODE","GAL","FARX","FXY","DFCF","FPAG","APIE","HEWJ","RDFI","ESGX","VYMI","ANEW","XCOR","FFDI","MXI","FLSP","RFCI","FDCE","NBGX","TOTL","IVLU","FVC","RIGS","CGIC","DDWM","IQDY","PTIN","AVIV","TUG","WLDR","PPIE","BINV","JFLI","WLTG","BK4550","YCL","AMAX","EWJ","TOAK","RFDI","ATFV","PDN","CGV","ACWX","DYFI","HIDV","EDGI","ERNZ","RJMG","VGFPF","DBAW","EDGF","BK4582","BKIV","BGRO","AVNV","SSXU","DWCR","MJYmain","PSDM","YLDE","FIRS","CVY","JDVI","PYLD","TEK","IDMO","JIII","FIXP","UIVM","IMTM","OGIG","MFSG","CGUS","JPIB","PIZ","JPYmain","DFAX","ROIS","FLDZ","PIM","CGDV","INTL","TOK","BK4585","QWLD","IFV","USAF","ROMO","DMX","MVFG","DTAN","PEXL","VSLU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651846355","title":"aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651846355","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651846355?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:00","pubTimestamp":1784116800,"startTime":"0","endTime":"0","summary":"Patients with restrictive lung disease demonstrate clinically meaningful benefit in FVC and improvements in multiple PROs for 5.0 mg/kg efzofitimod compared to placebo.  Company submitted protocol to ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/15/3327639/0/en/aTyr-Pharma-to-Present-Subgroup-Analysis-of-Phase-3-EFZO-FIT-Study-of-Efzofitimod-in-Pulmonary-Sarcoidosis-at-WASOG-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650975642","title":"Bitcoin slips below the cloud as Ethereum and Altcoins show relative strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2650975642","media":"Kitco","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650975642?lang=en_us&edition=fundamental","pubTime":"2026-07-09 15:21","pubTimestamp":1783581660,"startTime":"0","endTime":"0","summary":"Bitcoin dropped below the daily TBO Cloud on Wednesday, which technically puts it back in strong bearish mode. But the move is not as simple as it looks. The daily TBO Slow line is flattening and OBV ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"kitco_highlight","url":"https://www.kitco.com/opinion/2026-07-09/bitcoin-slips-below-cloud-ethereum-and-altcoins-show-relative-strength","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.kitco.com/opinion/2026-07-09/bitcoin-slips-below-cloud-ethereum-and-altcoins-show-relative-strength","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"kitco_highlight","symbols":["BPI","GDLC","BFAP","YETH","CBTY","DIME","09009","ETHE","09046","BITW","ESK","ETHV","ETCO","METHmain","EETH","FETH","NCIQ","EZET","LFGY","BKCH","CBXY","BEGS","09042","RSMV","CBOO","QETH","CBOJ","BFJL","09008","GXDW","AETH","CETH","BETH","BTF","ETH","ETU","ETHU","09439","CRPT","ETHA","FVC","STCE","ETHT","ARKY","BITQ","ETHD","09179","BETE","ETHW","IBIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193999378","title":"South Korean Won Strengthens Against US Dollar, Reaching Highest Level Since Late May","url":"https://stock-news.laohu8.com/highlight/detail?id=1193999378","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193999378?lang=en_us&edition=fundamental","pubTime":"2026-07-08 14:32","pubTimestamp":1783492322,"startTime":"0","endTime":"0","summary":"The South Korean won continues its upward trend, appreciating to its strongest level in nearly six weeks.The US dollar fell by 1% against the won, reaching 1500.20, marking its lowest level since May 29th.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACWX","RJMG","BGRO","CGDV","BK4535","GDMA","IQDY","URTH","DMX","MVFG","DXIV","QDF","AHLT","FDCE","BK4582","DDWM","INTF","JFLI","FLSP","AVNV","DWCR","IFV","UIVM","TOUS","IDMO","JIII","AVDV","AAVM","BINV","JCPI","FVC","SIO","TOAK","VYMI","ESGX","FLDZ","JHMD","CGUS","PRAE","VGFPF","LEXI","CGV","YLDE","MXI","ATFV","WWJD","WBND","FTRB","IYLD","PSDM","RLY","EDGI","JPIE","GLBL","TEK","USAF","APIE","JDVI","XCOR","NBGX","GAL","HCRB","WLDR","PIM","CGIC","EDGF","MFSG","WTMF","EWY","CGGE","FIRS","PPIE","RTRE","AVIV","ANEW","EAGL","RODE","TUG","KUmain","NTZG","BK4550","FIXP","TOTL","IMTM","BKIV","ROIS","JPIB","FPAG","ERNZ","PDN","KORU","IVAL","RIGS","ITDE","BGH","SCHC","IVLU","PYLD","RFDI","HIDV","FID","ROMO","DFAX","PEXL","RDFI","WLTG","UNIY","TOK","SSXU","AMAX","VSLU","ISEP","FARX","QWLD","BK4588","DBAW","CVY","PIZ","DTAN","DFCF","OGIG","MKOR","FFDI","TBG","INTL","DYFI","DDX","BK4585","RFCI","FLKR","PTIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142104797","title":"Quantitative Hedge Funds Face Sharpest Drawdown Since 2023 as Momentum Strategy Falters","url":"https://stock-news.laohu8.com/highlight/detail?id=1142104797","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142104797?lang=en_us&edition=fundamental","pubTime":"2026-07-07 00:41","pubTimestamp":1783356112,"startTime":"0","endTime":"0","summary":"Amid the ongoing bull market, intense sector rotations within equities have triggered the most severe drawdown for quantitative hedge funds since 2023. An index from S&P Global indicates that a...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FVC","TPMN","DDIV","VAMO","VFMO","PDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644745726","title":"Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2644745726","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644745726?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:00","pubTimestamp":1781697600,"startTime":"0","endTime":"0","summary":"Company expects to report topline 12-month clinical results in the second half of 2027BOSTON, June  17, 2026  (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN) (Avalyn or the Company), a clinical-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/17/3313361/0/en/Avalyn-Completes-Target-Enrollment-in-Phase-2b-MIST-Trial-of-AP01-Inhaled-Pirfenidone-for-Patients-with-Progressive-Pulmonary-Fibrosis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1069347547.HKD","SG9999003800.SGD","LU0772969993.USD","MIST","BK4007","IE00BJJMRY28.SGD","LU0742537680.HKD","LU0353189680.USD","LU1235295455.SGD","LU2108987350.USD","IE00BJJMRX11.SGD","IE0004445239.USD","BK4107","LU1718418525.SGD","LU0170899867.USD","BK4588","LU0354030511.USD","IE00B775H168.HKD","LU0731783394.SGD","LU1599440770.SGD","IE0005OL40V9.USD","LU1366192091.USD","LU1430594728.SGD","PGR","LU0354030438.USD","LU1481011671.HKD","IE00BFSS7M15.SGD","BK4533","SG9999004303.SGD","SGXZ23171101.USD","IE0004445015.USD","LU1481011911.USD","LU0289960550.SGD","BK4585","LU0138981039.USD","LU0320765489.SGD","LU1035773651.USD","IE00BFSS8Q28.SGD","LU2355687059.USD","LU1509826696.USD","LU2087625088.SGD","LU0208291251.USD","IE00BZ1G4Q59.USD","LU0731783048.USD","LU1585245621.USD","IE00B4JS1V06.HKD","IE00BKVL7J92.USD","FVC","IE00BN29S564.USD","LU1983260115.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635671084","title":"aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635671084","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635671084?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:00","pubTimestamp":1778846400,"startTime":"0","endTime":"0","summary":"Company to continue development of efzofitimod in pulmonary sarcoidosis following Type C meeting with the FDA. Company plans to submit an IND in June 2026 for a Phase 3 study of efzofitimod in patient","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/15/3295781/0/en/aTyr-Pharma-Announces-First-Quarter-2026-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","FVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634232659","title":"aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2634232659","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634232659?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:01","pubTimestamp":1778529660,"startTime":"0","endTime":"0","summary":"Company to continue development of efzofitimod in pulmonary sarcoidosis incorporating FDA feedback. Company plans to submit IND in June 2026 for new Phase 3 study of efzofitimod in patients with chron","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3292283/0/en/aTyr-Pharma-Provides-Regulatory-and-Clinical-Update-for-Efzofitimod-in-Pulmonary-Sarcoidosis-Following-FDA-Type-C-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCS","BK4007","IND","BK4585","BK4588","FVC","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623346797","title":"Why Is United Therapeutics Stock Soaring Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2623346797","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623346797?lang=en_us&edition=fundamental","pubTime":"2026-03-30 22:08","pubTimestamp":1774879680,"startTime":"0","endTime":"0","summary":"The study demonstrated that nebulized Tyvaso  significantly improved forced vital capacity  by 130.1 mL compared to placebo.The drug also reduced the risk of clinical worsening in patients with idiopathic pulmonary fibrosis .IPF is a chronic, progressive lung disease characterized by irreversible scarring of lung tissue, leading to severe breathing difficulties. ‘Idiopathic’ means the cause is unknown.Integrated analyses of the TETON-1 and TETON-2 studies showed statistically significant treatment effects across most secondary efficacy endpoints.The treatment was well-tolerated, with no new safety signals reported, reinforcing the robustness of the findings across various patient subgroups.United Therapeutics plans to seek priority review of a supplemental New Drug Application, to be submitted to the U.S. Food and Drug Administration  by the end of this summer, to add IPF to the labeled indications based on data from the TETON-1 and TETON-2 studies.Earlier in March, United Therapeutics","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/30/Lung-cancer-study.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/30/Lung-cancer-study.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/26/03/51539658/why-is-united-therapeutics-stock-soaring-monday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/03/51539658/why-is-united-therapeutics-stock-soaring-monday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["FVC","UTHR","LU1699723380.USD","BK4532","BK4139","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618274899","title":"BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9","url":"https://stock-news.laohu8.com/highlight/detail?id=2618274899","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618274899?lang=en_us&edition=fundamental","pubTime":"2026-03-12 02:00","pubTimestamp":1773252000,"startTime":"0","endTime":"0","summary":"- Phase 3 FORTIFY interim analysis results presented in a late-breaking oral presentationat MDA highlight the broad and consistent efficacy of BBP-418 across key clinical endpoints and prespecified su","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/11/3254081/0/en/BBP-418-Demonstrates-Consistent-Efficacy-and-Favorable-Safety-Profile-in-Phase-3-FORTIFY-Interim-Analysis-in-LGMD2I-R9.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBP","FVC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}